A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/2001
12/27/2001	WO2001097801A2 Dry powder formulation comprising racecadotril
12/27/2001	WO2001097795A2 Systems and methods for treating a mucosal surface
12/27/2001	WO2001097779A2 Improved injectable dispersions of propofol
12/27/2001	WO2001097753A2 Novel methods using pyridine derivatives
12/27/2001	WO2001085719A9 Ortho-substituted anthranilic acid amides and their use as medicaments
12/27/2001	WO2001077109A3 Sodium salt of an azo derivative of 5-aminosalicylic acid
12/27/2001	WO2001060349B1 Pharmacological agent comprising picolinic acid, fusaric acid and derivatives thereof.
12/27/2001	WO2001057042A3 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy
12/27/2001	WO2001049711A3 Nucleic acids encoding (poly)peptides having chips activity
12/27/2001	WO2001046256A3 Vesicle trafficking proteins
12/27/2001	WO2001034614A3 Compositions and methods for double-targeting virus infections and targeting cancer cells
12/27/2001	WO2001032646A3 Sulfonamide derivatives
12/27/2001	WO2001021159A3 Pharmaceutical composition of nateglinide and another antidiabetcagent
12/27/2001	WO2000055109A9 Lipoxin compounds and their use
12/27/2001	WO1999056780A8 Isomer enriched conjugated linoleic acid compositions
12/27/2001	US20010056184 Pipecolinic acid derivatives, method of manufacturing the same and therapeutic agents containing these compounds
12/27/2001	US20010056183 Sulfonamides and derivatives thereof that modulate the activity of endothelin
12/27/2001	US20010056113 Methods for the inhibition of angiogenesis with 6-amino EM-12
12/27/2001	US20010056106 Substituted phenylamino(methylcyclobutene) derivatives are useful in treating gastrointestinal disorders associated with antagonizing the the motillin receptor
12/27/2001	US20010056100 Carboxylic acid or tetrazole derivatives containing carbamate groups are useful for treating the conditions associated with the urinary tract, pain, inflammation, respiratory states, edema formation of hypotensive vascular diseases
12/27/2001	US20010056092 Diaminocyclobutene-3,4-dione derivatives, their preparation and use
12/27/2001	US20010055788 Recombinant bacterial phytases and uses thereof
12/27/2001	US20010055745 Method and device for preparing a dental implant by immersion in a culture of mesenchymal cells
12/27/2001	US20010055616 Multilayer; active material core, enteric coating
12/27/2001	CA2414228A1 Secreted epithelial colon stromal-1 polypeptides, nucleic acids encoding the same and uses thereof
12/27/2001	CA2414015A1 Human receptors
12/27/2001	CA2414010A1 Secreted redox proteins
12/27/2001	CA2413986A1 Gp354 nucleic acids and polypeptides
12/27/2001	CA2413878A1 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders
12/27/2001	CA2413754A1 Canine hepatocyte growth factor
12/27/2001	CA2413454A1 A g-protein coupled receptor
12/27/2001	CA2413435A1 A recombinant cell line expressing gpcrx11 as a functional receptor validated by angiopeptin and useful for screening of agonists and antagonists
12/27/2001	CA2413421A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
12/27/2001	CA2413418A1 Piperidine amides as modulators of chemokine receptor activity
12/27/2001	CA2413274A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
12/27/2001	CA2413253A1 Matrix protein compositions for dentin regeneration
12/27/2001	CA2412905A1 Improved injectable dispersions of propofol
12/27/2001	CA2412484A1 G-protein coupled receptors
12/27/2001	CA2412362A1 Cox-2 inhibitors and the prevention of the side effects of radiation therapy
12/27/2001	CA2412215A1 Angiogenesis-modulating compositions and uses
12/27/2001	CA2412188A1 3-azabicyclo¬3.1.0\|hexane derivatives useful in therapy
12/27/2001	CA2412011A1 Chemically-modified antimicrobial peptides, compositions and methods of production and use
12/27/2001	CA2411971A1 Proteases
12/27/2001	CA2411857A1 Peptides, compositions and methods for the treatment of burkholderia cepacia
12/27/2001	CA2411585A1 Novel non-psychotropic cannabinoids
12/27/2001	CA2411236A1 Combinations and compositions which interfere with vegf/vegf and angiopoietin/tie receptor function and their use (ii)
12/27/2001	CA2410632A1 Nitrosated and nitrosylated taxanes, compositions and methods of use
12/27/2001	CA2410447A1 Bis-arylsulfones
12/27/2001	CA2410224A1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains
12/27/2001	CA2410208A1 Systems and methods for treating a mucosal surface
12/27/2001	CA2409778A1 Secreted proteins
12/27/2001	CA2409776A1 G-protein coupled receptors
12/26/2001	CN1328569A TGF (b) 1 inhibitor peptides
12/26/2001	CN1328555A Novel salts of pyridopyrazine compound and crystals thereof
12/26/2001	CN1328554A Eletriptan hydrobromide monohydrate
12/26/2001	CN1328545A Hydrazine derivatives
12/26/2001	CN1328538A 2,4-pentadienoic acid derivatives having selective activity for retinoid X(RXR) receptors
12/26/2001	CN1328457A Use of N-substituted-1,5-dideoxy -1,5-imino-D-glucitol compounds for treating hepatitis virus
12/26/2001	CN1328447A Process for producing particles with converted amorphous and/or meta-stable crystalline region into crystalline state
12/26/2001	CN1328441A Methods of reducing astringency of stannous in dentifrice compositions
12/26/2001	CN1328417A Compositions and methods for treatment of mitochondrial diseases
12/26/2001	CN1327854A Composite lysostaphin enzyme spray for oral cavity and its preparing process
12/26/2001	CN1327848A Chinese medicine for treating habitual constipation
12/26/2001	CN1327845A Application of medicinal composition in preparing medicine to treat hepatitis B
12/26/2001	CN1327842A Oral liquid for losing weight and refreshing
12/26/2001	CN1327825A Caspule for treating gastrosis
12/26/2001	CN1327819A Royal jelly-pollen tea
12/26/2001	CN1327806A Compound Cijin capsule
12/26/2001	CN1327799A Mixture of white pepper and borneol and its application
12/26/2001	CN1327793A Pyrrolo-triazine and pyrimidine compounds
12/26/2001	CN1076624C Nasally administrable compositions
12/26/2001	CN1076616C Pure natural health-care article for eliminating smoke harm
12/26/2001	CN1076611C Exterior-applied medicine 'Yiganzhuanyin liquid' for transforming surface antigen of hepatitis B from positive to negative and its preparing process
12/26/2001	CN1076610C Mongolia patent drug for treating peptide ulcer
12/26/2001	CN1076609C Chinese medicine for curing gastritis and duodenal ulcer
12/26/2001	CA2350043A1 Novel melanocortin -4 receptor sequences and screening assays to identify compounds useful in regulating animal appetite and metabolic rate
12/25/2001	US6333353 Nutrients, foods, drugs
12/25/2001	US6333341 Tumor necrosis factor, antiinflammatory agents and analgesics
12/25/2001	US6333328 Serotonin 5-HT3 receptor partial activator
12/25/2001	US6333325 Method of treating cytokine mediated diseases or conditions
12/25/2001	US6333188 Lactic acid bacteria preparation having biopurification activity
12/25/2001	CA2209313C Heterocycle-fused thiazole derivatives
12/22/2001	CA2351250A1 Method for stimulating liver regeneration
12/21/2001	CA2351129A1 Novel substituted nitrocatechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them
12/21/2001	CA2351125A1 Substituted nitrated catechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them
12/20/2001	WO2001096603A2 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions
12/20/2001	WO2001096586A1 Antisense modulation of c/ebp alpha expression
12/20/2001	WO2001096567A1 Novel g protein-coupled receptor protein and dna thereof
12/20/2001	WO2001096553A1 Novel g protein-coupled receptor protein and dna thereof
12/20/2001	WO2001096547A2 Human kinases
12/20/2001	WO2001096546A2 Protein phosphatases
12/20/2001	WO2001096397A2 Cd154 variants and uses thereof
12/20/2001	WO2001096347A1 HMG-CoA REDUCTASE INHIBITORS AND METHOD
12/20/2001	WO2001096327A1 BIOISOSTERIC BENZAMIDE DERIVATIVES AND THEIR USE AS APoB-100 SECRETION INHIBITORS
12/20/2001	WO2001096323A1 Serine protease inhibitors
12/20/2001	WO2001096311A2 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases
12/20/2001	WO2001096310A1 Dihydrostilbene alkanoic acid derivatives useful as vitronectin antagonists
12/20/2001	WO2001096308A1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof
12/20/2001	WO2001096305A1 Serine protease inhibitors
12/20/2001	WO2001096302A1 Piperidines for use as orexin receptor antagonists

1 ... 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 ... 1258